Marksans Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma Limited has informed the stock exchanges that its trading window will remain closed starting Tuesday, July 1, 2025, in line with SEBI's Prohibition of Insider Trading Regulations, 2015. The window will stay shut until 48 hours after the company declares its unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26). During this period, designated persons (insiders) and their immediate relatives are prohibited from trading in the company's shares. The exact date of the results announcement will be communicated separately. This is a routine compliance filing typically made ahead of quarterly results.
No direct impact on shareholders or stock price. This is a standard regulatory compliance announcement. It does signal that Q1 FY26 earnings are due soon, which investors should watch for as it could influence short-term stock movement.